Source: Eur Respir J 2008; 31: 126-134
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
van Albada M. E., du Marchie Sarvaa... G. J., Koster J., Houwertjes M. C., Berger R. M. F., Schoemaker R. G.. Effects of erythropoietin on advanced pulmonary vascular remodelling. Eur Respir J 2008; 31: 126-134

Member's Comments

No comment yet.

Related content which might interest you: Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2013; 41: 224-232 Year: 2013 In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension Year: 2007 Cardiac remodelling and hemodynamic changes in pulmonary hypertension after double lung transplantation Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target Source: Eur Respir J 2011; 38: 1453-1460 Year: 2011 Right ventricular function changes after therapy in chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Association of renal dysfunction with hemodynamics and survival in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 The different nature of pulmonary vascular resistant and compliance in reduced and preserved ejection fraction heart failure and associated pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange Year: 2014 Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Native myocardial T1 correlates with right ventricular remodelling in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Molecular determinants of cardiac and pulmonary vascular remodeling in scleroderma-related pulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases Year: 2008 Chronic thromboembolic pulmonary hypertension: animal models Source: Eur Respir J 2013; 41: 1200-1206 Year: 2013 The association between resting and mild-to-moderate exercise pulmonary artery pressure Source: Eur Respir J 2012; 39: 313-318 Year: 2012 Mast cells promote lung vascular remodelling in pulmonary hypertension Source: Eur Respir J 2011; 37: 1400-1410 Year: 2011 mir-126 contribute to angiogenesis defect in pulmonary arterial hypertension right ventricle failure Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease Source: Eur Respir J 2013; 41: 217-223 Year: 2013 Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 1286-1293 Year: 2010